These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8583355

  • 1. Comparison of behavioural effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine alone on behavioural sensitization and conditioned response.
    Yui K, Miura T, Sugiyama K, Ono M, Nagase M.
    J Pharm Pharmacol; 1995 Oct; 47(10):852-6. PubMed ID: 8583355
    [Abstract] [Full Text] [Related]

  • 2. Effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine on behavioral sensitization and conditioning.
    Yui K, Miura T, Sugiyama K, Ono M, Nagase M.
    Behav Brain Res; 1996 Oct; 80(1-2):169-75. PubMed ID: 8905140
    [Abstract] [Full Text] [Related]

  • 3. Methamphetamine plus scopolamine potentiates behavioral sensitization and conditioning.
    Yui K, Miura T, Sugiyama K, Ono M, Nagase M.
    Eur J Pharmacol; 1995 Jun 12; 279(2-3):135-42. PubMed ID: 7556393
    [Abstract] [Full Text] [Related]

  • 4. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K, Miura T, Sugiyama K, Ono M, Nagase M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun 12; 14(3):169-78. PubMed ID: 7941782
    [Abstract] [Full Text] [Related]

  • 5. Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats.
    Yui K, Miura T.
    Neuropsychobiology; 1996 Jun 12; 33(1):21-7. PubMed ID: 8821371
    [Abstract] [Full Text] [Related]

  • 6. Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.
    Ohmori T, Abekawa T, Koyama T.
    Psychopharmacology (Berl); 1995 Sep 12; 121(2):158-63. PubMed ID: 8545520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC, Lao CL, Chen JC.
    J Neurochem; 2007 Jan 12; 100(1):225-41. PubMed ID: 17101033
    [Abstract] [Full Text] [Related]

  • 14. [Cholinergic modulation on stereotyped behavior and behavioral hypersensitivity (reverse tolerance) in rats].
    Yui K, Miura T.
    Yakubutsu Seishin Kodo; 1991 Apr 12; 11(2):141-56. PubMed ID: 1927059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.
    Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S.
    Psychopharmacology (Berl); 1989 Apr 12; 98(1):89-92. PubMed ID: 2498964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.